14 Current news of Illumina
rss |
You can refine your search further. Select from the filter options on the left to narrow down your results. |
05-Nov-2018
Illumina, Inc. and Pacific Biosciences announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction. This price represents a premium of 71% to Pacific Biosciences’ 30 trading day volume weighted ...
Access provided by Co-Marketing agreement with Illumina
09-Mar-2017
Analytik Jena has entered a partnership with Illumina, Inc. headquartered in San Diego. In so doing Analytik Jena gains access to the growing genotyping market currently being served by Illumina’s technologies by offering a production scale solution to provide ultra-high throughput sample ...
12-Mar-2015
Merck Serono and Illumina, Inc., announced a collaboration to expand the development of a universal next-generation sequencing-based oncology diagnostic for clinical trials of targeted cancer therapies. Under the terms of the agreement, Merck Serono and Illlumina will work together to develop ...
Uncovering Mutations Found in Deadly Transmissible Cancer Could Help Conservation Efforts
20-Sep-2010
Researchers from Illumina, Inc. and the Wellcome Trust Sanger Institute have used Illumina's next generation sequencing technology to create a draft genome sequence for the endangered Tasmanian devil, and will use this to find genetic mutations in the transmissible cancer that is ravaging its ...
Offering to Provide Comprehensive Image of Individual Whole Genome
12-Jun-2009
Illumina, Inc. has unveiled a service program to provide high-quality personal genome sequencing for consumers. This is the first service to offer complete coverage of the human genome sequence for under $50,000. The Personal Genome Sequencing Service is performed in Illumina’s recently certified ...
Single-Molecule DNA Sequencing System Promises Dramatic Improvement in Cost, Speed, Versatility, and Simplicity of Sequencing
14-Jan-2009
Illumina and Oxford Nanopore Technologies announced a strategic alliance including a commercialization agreement and equity investment. Under the terms of the commercialization agreement, Illumina will exclusively market, sell, distribute, and service BASE™ Technology products developed by Oxford ...
13-Jan-2009
Illumina announced that researchers at the Beijing Genomics Institute (BGI), Shenzhen are the first to complete de novo sequencing of the giant panda genome. A small team of scientists in one month produced 150 gigabases of sequence that was used to assemble the three gigabase genome belonging to ...
Biotech Innovators Will Contribute to International Effort To Produce Most Detailed Map of Genetic Variation
13-Jun-2008
Leaders of the 1000 Genomes Project announced that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to date of human genetic variation as a tool for medical research. The new participants are: Applied ...
Accomplishment Marks a Significant Milestone Enabling Economical Human Genome Resequencing
11-Feb-2008
Illumina, Inc. announced that scientists at the Company have sequenced the genome of an anonymous African male (Yoruba from Ibadan, Nigeria), using the Genome Analyzer. Sequencing of this HapMap sample was conducted internally and marks the first human genome sequence generated exclusively with ...
08-Jan-2008
Illumina, Inc. announced that it has reorganized its operating structure to further leverage the synergies between its sequencing and genotyping businesses. Under the new structure, a newly created Life Sciences Business Unit will include all products and services related to the research market ...
